Canadian Cancer Trials Group Bulletins


58th American Society of Hematology Annual Meeting

CCTG will be presenting one oral presentation and one poster and is part of three other abstracts at the American Society of Hematology (ASH) Annual Meeting and Symposium being held in San Diego from December 3-6, 2016.

Dr. Tanya Skamene, a Fellow at the CCTG Central Operations and Statistics Office, is presenting Impact of Wait Times for Autologous Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin Lymphoma, a Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial on Monday, December 5, 2016.

Dr. Kerry Savage, Medical Oncologist at the British Columbia Cancer Centre, Vancouver, is presenting the results of LY.15, A Phase I Study of Romidepsin, Gemcitabine, Dexamethasone and Cisplatin Combination Therapy in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma.

You can view more information about these presentations by using this link ...